{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T23:59:27Z","timestamp":1794268767111,"version":"4.9.0"},"reference-count":121,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T00:00:00Z","timestamp":1707177600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.biopha.2024.116261","type":"journal-article","created":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T23:49:17Z","timestamp":1707522557000},"page":"116261","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Therapeutic potential of MCC950, a specific inhibitor of NLRP3 inflammasome in systemic lupus erythematosus"],"prefix":"10.1016","volume":"172","author":[{"given":"Xiaoxiao","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juanjie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuyan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.biopha.2024.116261_bib1","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/nrrheum.2013.78","article-title":"Gene-function studies in systemic lupus erythematosus","volume":"9","author":"Crisp\u00edn","year":"2013","journal-title":"Nat. Rev. Rheuma"},{"issue":"12","key":"10.1016\/j.biopha.2024.116261_bib2","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/nrrheum.2016.186","article-title":"New insights into the immunopathogenesis of systemic lupus erythematosus","volume":"12","author":"Tsokos","year":"2016","journal-title":"Nat. Rev. Rheuma"},{"issue":"10188","key":"10.1016\/j.biopha.2024.116261_bib3","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1016\/S0140-6736(19)30237-5","article-title":"Management strategies and future directions for systemic lupus erythematosus in adults","volume":"393","author":"Durcan","year":"2019","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.biopha.2024.116261_bib4","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/rheumatology\/kex286","article-title":"The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults","volume":"57","author":"Gordon","year":"2018","journal-title":"Rheumatol. (Oxf. )"},{"issue":"12","key":"10.1016\/j.biopha.2024.116261_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029539","article-title":"The cytokine release inhibitory drug CRID3 targets ASC oligomerisation in the NLRP3 and AIM2 inflammasomes","volume":"6","author":"Coll","year":"2011","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.biopha.2024.116261_bib6","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1080\/13543776.2023.2239502","article-title":"A patent review of NLRP3 inhibitors to treat autoimmune diseases","volume":"33","author":"Xu","year":"2023","journal-title":"Expert Opin. Ther. Pat."},{"issue":"8","key":"10.1016\/j.biopha.2024.116261_bib7","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/ni.1636","article-title":"The NALP3 inflammasome is involved in the innate immune response to amyloid-beta","volume":"9","author":"Halle","year":"2008","journal-title":"Nat. Immunol."},{"issue":"13","key":"10.1016\/j.biopha.2024.116261_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14133150","article-title":"The role of the NLRP3 inflammasome in HCC carcinogenesis and treatment: harnessing innate immunity","volume":"14","author":"Papadakos","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.biopha.2024.116261_bib9","doi-asserted-by":"crossref","DOI":"10.1038\/cddiscovery.2016.19","article-title":"Questions and controversies in innate immune research: what is the physiological role of NLRP3?","volume":"2","author":"Coll","year":"2016","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.biopha.2024.116261_bib10","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3389\/fimmu.2013.00333","article-title":"Functions of NOD-like receptors in human diseases","volume":"4","author":"Zhong","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2024.116261_bib11","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3389\/fimmu.2013.00285","article-title":"Unsolved mysteries in NLR biology","volume":"4","author":"Lupfer","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2024.116261_bib12","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3389\/fphar.2015.00262","article-title":"NLRP3 inflammasome and its inhibitors: a review","volume":"6","author":"Shao","year":"2015","journal-title":"Front Pharmacol."},{"issue":"13","key":"10.1016\/j.biopha.2024.116261_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20133328","article-title":"The NLRP3 inflammasome: an overview of mechanisms of activation and regulation","volume":"20","author":"Kelley","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2024.116261_bib14","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/cmi.2015.95","article-title":"Molecular mechanisms regulating NLRP3 inflammasome activation","volume":"13","author":"Jo","year":"2016","journal-title":"Cell Mol. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2024.116261_bib15","doi-asserted-by":"crossref","first-page":"787","DOI":"10.4049\/jimmunol.0901363","article-title":"Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression","volume":"183","author":"Bauernfeind","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2024.116261_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.820541","article-title":"Canagliflozin ameliorates NLRP3 inflammasome-mediated inflammation through inhibiting NF-\u03baB signaling and upregulating Bif-1","volume":"13","author":"Niu","year":"2022","journal-title":"Front Pharmacol."},{"issue":"4","key":"10.1016\/j.biopha.2024.116261_bib17","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.7314\/APJCP.2012.13.4.1365","article-title":"HMGB1 promotes the synthesis of pro-IL-1\u03b2 and pro-IL-18 by activation of p38 MAPK and NF-\u03baB through receptors for advanced glycation end-products in macrophages","volume":"13","author":"He","year":"2012","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.biopha.2024.116261_bib18","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3389\/fmicb.2014.00438","article-title":"Mitochondrial ROS potentiates indirect activation of the AIM2 inflammasome","volume":"5","author":"Crane","year":"2014","journal-title":"Front Microbiol"},{"issue":"1","key":"10.1016\/j.biopha.2024.116261_bib19","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00011-013-0667-3","article-title":"OxLDL-induced IL-1 beta secretion promoting foam cells formation was mainly via CD36 mediated ROS production leading to NLRP3 inflammasome activation","volume":"63","author":"Liu","year":"2014","journal-title":"Inflamm. Res."},{"issue":"1","key":"10.1016\/j.biopha.2024.116261_bib20","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.cellimm.2015.06.002","article-title":"Genipin suppresses NLRP3 inflammasome activation through uncoupling protein-2","volume":"297","author":"Rajanbabu","year":"2015","journal-title":"Cell Immunol."},{"issue":"8","key":"10.1016\/j.biopha.2024.116261_bib21","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/ni.1631","article-title":"Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization","volume":"9","author":"Hornung","year":"2008","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.biopha.2024.116261_bib22","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.cell.2014.04.007","article-title":"Mechanisms and functions of inflammasomes","volume":"157","author":"Lamkanfi","year":"2014","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.biopha.2024.116261_bib23","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/ni.1703","article-title":"The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis","volume":"10","author":"Franchi","year":"2009","journal-title":"Nat. Immunol."},{"issue":"9","key":"10.1016\/j.biopha.2024.116261_bib24","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1016\/j.apsb.2021.02.006","article-title":"Gasdermin D in pyroptosis","volume":"11","author":"Burdette","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"2","key":"10.1016\/j.biopha.2024.116261_bib25","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jmb.2017.09.019","article-title":"How inflammasomes inform adaptive immunity","volume":"430","author":"Evavold","year":"2018","journal-title":"J. Mol. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116261_bib26","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1038\/s41467-019-09401-9","article-title":"IL-4 together with IL-1\u03b2 induces antitumor Th9 cell differentiation in the absence of TGF-\u03b2 signaling","volume":"10","author":"Xue","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2024.116261_bib27","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1146\/annurev.immunol.021908.132612","article-title":"Immunological and inflammatory functions of the interleukin-1 family","volume":"27","author":"Dinarello","year":"2009","journal-title":"Annu Rev. Immunol."},{"issue":"12","key":"10.1016\/j.biopha.2024.116261_bib28","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.imbio.2012.07.020","article-title":"Acute lipopolysaccharide priming boosts inflammasome activation independently of inflammasome sensor induction","volume":"217","author":"Schroder","year":"2012","journal-title":"Immunobiology"},{"issue":"13","key":"10.1016\/j.biopha.2024.116261_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.cub.2016.02.019","article-title":"Pyroptosis","volume":"26","author":"Vande Walle","year":"2016","journal-title":"Curr. Biol."},{"issue":"43","key":"10.1016\/j.biopha.2024.116261_bib30","doi-asserted-by":"crossref","first-page":"36617","DOI":"10.1074\/jbc.M112.407130","article-title":"Non-transcriptional priming and deubiquitination regulate NLRP3 inflammasome activation","volume":"287","author":"Juliana","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2024.116261_bib31","doi-asserted-by":"crossref","first-page":"1118180","DOI":"10.3389\/fimmu.2022.1118180","article-title":"Editorial: Systemic lupus erythematosus - predisposition factors, pathogenesis, diagnosis, treatment and disease models","volume":"13","author":"Nandakumar","year":"2022","journal-title":"Front Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116261_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/08916934.2021.1995860","article-title":"The role of NLRP3 inflammasome in the pathogenesis of rheumatic disease","volume":"55","author":"Kong","year":"2022","journal-title":"Autoimmunity"},{"issue":"2","key":"10.1016\/j.biopha.2024.116261_bib33","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/cei.13167","article-title":"NLRP3 inflammasome activation contributes to the pathogenesis of rheumatoid arthritis","volume":"194","author":"Guo","year":"2018","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116261_bib34","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12967-016-0911-z","article-title":"Anti-dsDNA antibodies bind to TLR4 and activate NLRP3 inflammasome in lupus monocytes\/macrophages","volume":"14","author":"Zhang","year":"2016","journal-title":"J. Transl. Med"},{"issue":"9","key":"10.1016\/j.biopha.2024.116261_bib35","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1002\/art.40166","article-title":"Enhanced inflammasome activity in systemic lupus erythematosus is mediated via type i interferon-induced up-regulation of interferon regulatory factor 1","volume":"69","author":"Liu","year":"2017","journal-title":"Arthritis Rheuma"},{"key":"10.1016\/j.biopha.2024.116261_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110542","article-title":"Role of the NLRP3 inflammasome in autoimmune diseases","volume":"130","author":"Li","year":"2020","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2024.116261_bib37","article-title":"Checkpoint connecting innate and adaptive immunity in autoimmune diseases","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2024.116261_bib38","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3389\/fimmu.2013.00319","article-title":"Nucleic Acid sensors and type I interferon production in systemic lupus erythematosus","volume":"4","author":"Shrivastav","year":"2013","journal-title":"Front Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116261_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/cei.13041","article-title":"Self-dsDNA in the pathogenesis of systemic lupus erythematosus","volume":"191","author":"Bai","year":"2018","journal-title":"Clin. Exp. Immunol."},{"issue":"22","key":"10.1016\/j.biopha.2024.116261_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212476","article-title":"The Role of NLRP3 Inflammasome in Lupus Nephritis","volume":"22","author":"Oliveira","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2024.116261_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.05.014","article-title":"Pathogenesis of lupus nephritis: RIP3 dependent necroptosis and NLRP3 inflammasome activation","volume":"103","author":"Guo","year":"2019","journal-title":"J. Autoimmun."},{"issue":"2","key":"10.1016\/j.biopha.2024.116261_bib42","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1186\/ar2964","article-title":"Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus","volume":"12","author":"Shah","year":"2010","journal-title":"Arthritis Res Ther."},{"issue":"7","key":"10.1016\/j.biopha.2024.116261_bib43","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1136\/annrheumdis-2021-221985","article-title":"Tfh cells with NLRP3 inflammasome activation are essential for high-affinity antibody generation, germinal centre formation and autoimmunity","volume":"81","author":"Zhao","year":"2022","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.biopha.2024.116261_bib44","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/eji.201545760","article-title":"T follicular helper (Tfh) cells in lupus: Activation and involvement in SLE pathogenesis","volume":"46","author":"Blanco","year":"2016","journal-title":"Eur. J. Immunol."},{"issue":"10","key":"10.1016\/j.biopha.2024.116261_bib45","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41584-020-0480-7","article-title":"New insights into the role of antinuclear antibodies in systemic lupus erythematosus","volume":"16","author":"Pisetsky","year":"2020","journal-title":"Nat. Rev. Rheuma"},{"issue":"1","key":"10.1016\/j.biopha.2024.116261_bib46","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1600-065X.2011.01044.x","article-title":"Caspase-1-induced pyroptotic cell death","volume":"243","author":"Miao","year":"2011","journal-title":"Immunol. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2024.116261_bib47","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0022-3565(24)29317-4","article-title":"Identification and characterization of a novel class of interleukin-1 post-translational processing inhibitors","volume":"299","author":"Perregaux","year":"2001","journal-title":"J. Pharm. Exp. Ther."},{"issue":"6","key":"10.1016\/j.biopha.2024.116261_bib48","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41589-019-0278-6","article-title":"MCC950 closes the active conformation of NLRP3 to an inactive state","volume":"15","author":"Tapia-Abell\u00e1n","year":"2019","journal-title":"Nat. Chem. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116261_bib49","doi-asserted-by":"crossref","first-page":"8618","DOI":"10.1038\/s41598-018-26775-w","article-title":"MCC950, a specific small molecule inhibitor of NLRP3 inflammasome attenuates colonic inflammation in spontaneous colitis mice","volume":"8","author":"Perera","year":"2018","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.biopha.2024.116261_bib50","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat. Med"},{"issue":"41","key":"10.1016\/j.biopha.2024.116261_bib51","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2102975118","article-title":"Identification of fluoxetine as a direct NLRP3 inhibitor to treat atrophic macular degeneration","volume":"118","author":"Ambati","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.biopha.2024.116261_bib52","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s11096-023-01573-1","article-title":"The efficacy and safety of fluoxetine versus placebo for stroke recovery: a meta-analysis of randomized controlled trials","volume":"45","author":"Wu","year":"2023","journal-title":"Int J. Clin. Pharm."},{"issue":"6","key":"10.1016\/j.biopha.2024.116261_bib53","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.immuni.2009.05.005","article-title":"Inflammasome-mediated disease animal models reveal roles for innate but not adaptive immunity","volume":"30","author":"Brydges","year":"2009","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.biopha.2024.116261_bib54","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1093\/toxsci\/kfv152","article-title":"Setting Clinical Exposure Levels of Concern for Drug-Induced Liver Injury (DILI) Using Mechanistic in vitro Assays","volume":"147","author":"Shah","year":"2015","journal-title":"Toxicol. Sci."},{"issue":"6","key":"10.1016\/j.biopha.2024.116261_bib55","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1021\/acschembio.1c00218","article-title":"A Probe for NLRP3 Inflammasome Inhibitor MCC950 Identifies Carbonic Anhydrase 2 as a Novel Target","volume":"16","author":"Kennedy","year":"2021","journal-title":"ACS Chem. Biol."},{"issue":"12","key":"10.1016\/j.biopha.2024.116261_bib56","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1021\/acsmedchemlett.6b00198","article-title":"Identification, Synthesis, and Biological Evaluation of the Major Human Metabolite of NLRP3 Inflammasome Inhibitor MCC950","volume":"7","author":"Salla","year":"2016","journal-title":"ACS Med Chem. Lett."},{"issue":"6","key":"10.1016\/j.biopha.2024.116261_bib57","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.immuni.2013.05.016","article-title":"K\u207a efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter","volume":"38","author":"Mu\u00f1oz-Planillo","year":"2013","journal-title":"Immunity"},{"issue":"40","key":"10.1016\/j.biopha.2024.116261_bib58","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1812744115","article-title":"Chloride regulates dynamic NLRP3-dependent ASC oligomerization and inflammasome priming","volume":"115","author":"Green","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.biopha.2024.116261_bib59","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s41467-017-00227-x","article-title":"CLICs-dependent chloride efflux is an essential and proximal upstream event for NLRP3 inflammasome activation","volume":"8","author":"Tang","year":"2017","journal-title":"Nat. Commun."},{"issue":"29","key":"10.1016\/j.biopha.2024.116261_bib60","doi-asserted-by":"crossref","first-page":"12077","DOI":"10.1074\/jbc.M117.797126","article-title":"The intracellular chloride channel proteins CLIC1 and CLIC4 induce IL-1\u03b2 transcription and activate the NLRP3 inflammasome","volume":"292","author":"Domingo-Fern\u00e1ndez","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2024.116261_bib61","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3389\/fmolb.2020.00037","article-title":"MCC950, a Selective Inhibitor of NLRP3 Inflammasome, Reduces the Inflammatory Response and Improves Neurological Outcomes in Mice Model of Spinal Cord Injury","volume":"7","author":"Jiao","year":"2020","journal-title":"Front Mol. Biosci."},{"issue":"11","key":"10.1016\/j.biopha.2024.116261_bib62","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1089\/neu.2017.5344","article-title":"MCC950, the Selective Inhibitor of Nucleotide Oligomerization Domain-Like Receptor Protein-3 Inflammasome, Protects Mice against Traumatic Brain Injury","volume":"35","author":"Ismael","year":"2018","journal-title":"J. Neurotrauma"},{"issue":"12","key":"10.1016\/j.biopha.2024.116261_bib63","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.tibs.2016.09.002","article-title":"Mechanism and Regulation of NLRP3 Inflammasome Activation","volume":"41","author":"He","year":"2016","journal-title":"Trends Biochem Sci."},{"issue":"6","key":"10.1016\/j.biopha.2024.116261_bib64","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41589-019-0277-7","article-title":"MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition","volume":"15","author":"Coll","year":"2019","journal-title":"Nat. Chem. Biol."},{"issue":"9","key":"10.1016\/j.biopha.2024.116261_bib65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000354","article-title":"MCC950\/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibition","volume":"17","author":"Vande Walle","year":"2019","journal-title":"PLoS Biol."},{"issue":"12","key":"10.1016\/j.biopha.2024.116261_bib66","doi-asserted-by":"crossref","first-page":"12877","DOI":"10.21037\/apm-21-3472","article-title":"A narrative review of positive regulation of NLRP3 inflammasome in rheumatoid arthritis","volume":"10","author":"Zhuang","year":"2021","journal-title":"Ann. Palliat. Med"},{"issue":"6","key":"10.1016\/j.biopha.2024.116261_bib67","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/annrheumdis-2013-203276","article-title":"Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatment","volume":"73","author":"Mathews","year":"2014","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.biopha.2024.116261_bib68","first-page":"5","article-title":"Expression of NLRP3 inflammasome, cytokines and vascular mediators in the skin of systemic sclerosis patients","volume":"17","author":"Mart\u00ednez-God\u00ednez","year":"2015","journal-title":"Isr. Med Assoc. J."},{"issue":"3","key":"10.1016\/j.biopha.2024.116261_bib69","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jdermsci.2022.12.006","article-title":"Cathepsin B\/NLRP3\/GSDMD axis-mediated macrophage pyroptosis induces inflammation and fibrosis in systemic sclerosis","volume":"108","author":"Liu","year":"2022","journal-title":"J. Dermatol. Sci."},{"issue":"10","key":"10.1016\/j.biopha.2024.116261_bib70","doi-asserted-by":"crossref","first-page":"e299","DOI":"10.1093\/rheumatology\/keac273","article-title":"Effective ex vivo inhibition of cryopyrin-associated periodic syndrome (CAPS)-associated mutant NLRP3 inflammasome by MCC950\/CRID3","volume":"61","author":"Weber","year":"2022","journal-title":"Rheumatol. (Oxf. )"},{"issue":"4","key":"10.1016\/j.biopha.2024.116261_bib71","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s00204-019-02411-y","article-title":"Carbon nanotubes and crystalline silica stimulate robust ROS production, inflammasome activation, and IL-1\u03b2 secretion in macrophages to induce myofibroblast transformation","volume":"93","author":"Hindman","year":"2019","journal-title":"Arch. Toxicol."},{"issue":"4","key":"10.1016\/j.biopha.2024.116261_bib72","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/rheumatology\/kev416","article-title":"Real-life effectiveness of canakinumab in cryopyrin-associated periodic syndrome","volume":"55","author":"Kuemmerle-Deschner","year":"2016","journal-title":"Rheumatol. (Oxf. )"},{"issue":"1","key":"10.1016\/j.biopha.2024.116261_bib73","doi-asserted-by":"crossref","first-page":"R33","DOI":"10.1186\/ar4184","article-title":"The schedule of administration of canakinumab in cryopyrin associated periodic syndrome is driven by the phenotype severity rather than the age","volume":"15","author":"Caorsi","year":"2013","journal-title":"Arthritis Res Ther."},{"issue":"8","key":"10.1016\/j.biopha.2024.116261_bib74","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1002\/art.40155","article-title":"Podocyte Activation of NLRP3 Inflammasomes Contributes to the Development of Proteinuria in Lupus Nephritis","volume":"69","author":"Fu","year":"2017","journal-title":"Arthritis Rheuma"},{"issue":"6","key":"10.1016\/j.biopha.2024.116261_bib75","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.4049\/jimmunol.1600035","article-title":"Efficacy and Pharmacology of the NLRP3 Inflammasome Inhibitor CP-456,773 (CRID3) in Murine Models of Dermal and Pulmonary Inflammation","volume":"197","author":"Primiano","year":"2016","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.biopha.2024.116261_bib76","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/BOR.0000000000000088","article-title":"The inflammasome and lupus: another innate immune mechanism contributing to disease pathogenesis?","volume":"26","author":"Kahlenberg","year":"2014","journal-title":"Curr. Opin. Rheuma"},{"key":"10.1016\/j.biopha.2024.116261_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175091","article-title":"Therapeutic potential of MCC950, a specific inhibitor of NLRP3 inflammasome","volume":"928","author":"Li","year":"2022","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.biopha.2024.116261_bib78","doi-asserted-by":"crossref","first-page":"4139048","DOI":"10.1155\/2021\/4139048","article-title":"MCC950, the NLRP3 Inhibitor, Protects against Cartilage Degradation in a Mouse Model of Osteoarthritis","volume":"2021","author":"Ni","year":"2021","journal-title":"Oxid. Med Cell Longev."},{"issue":"7","key":"10.1016\/j.biopha.2024.116261_bib79","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/nan.12621","article-title":"NLRP3 inflammasome and endoplasmic reticulum stress in the epileptogenic zone in temporal lobe epilepsy: molecular insights into their interdependence","volume":"46","author":"Yue","year":"2020","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.biopha.2024.116261_bib80","doi-asserted-by":"crossref","first-page":"27912","DOI":"10.1038\/srep27912","article-title":"Reassessing the role of the NLRP3 inflammasome during pathogenic influenza A virus infection via temporal inhibition","volume":"6","author":"Tate","year":"2016","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.biopha.2024.116261_bib81","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1016\/j.celrep.2018.02.027","article-title":"S. aureus Evades Macrophage Killing through NLRP3-Dependent Effects on Mitochondrial Trafficking","volume":"22","author":"Cohen","year":"2018","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.biopha.2024.116261_bib82","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/15548627.2019.1603547","article-title":"Emerging views of mitophagy in immunity and autoimmune diseases","volume":"16","author":"Xu","year":"2020","journal-title":"Autophagy"},{"issue":"3","key":"10.1016\/j.biopha.2024.116261_bib83","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.clim.2012.07.001","article-title":"Metabolic regulation of organelle homeostasis in lupus T cells","volume":"144","author":"Caza","year":"2012","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.biopha.2024.116261_bib84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mito.2016.05.007","article-title":"The pathogenesis of systemic lupus erythematosus - From the viewpoint of oxidative stress and mitochondrial dysfunction","volume":"30","author":"Lee","year":"2016","journal-title":"Mitochondrion"},{"issue":"5","key":"10.1016\/j.biopha.2024.116261_bib85","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1084\/jem.20151876","article-title":"Oxidized mitochondrial nucleoids released by neutrophils drive type I interferon production in human lupus","volume":"213","author":"Caielli","year":"2016","journal-title":"J. Exp. Med"},{"issue":"11","key":"10.1016\/j.biopha.2024.116261_bib86","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrrheum.2013.147","article-title":"Oxidative stress in the pathology and treatment of systemic lupus erythematosus","volume":"9","author":"Perl","year":"2013","journal-title":"Nat. Rev. Rheuma"},{"issue":"11","key":"10.1016\/j.biopha.2024.116261_bib87","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1002\/art.39791","article-title":"Mitochondrial Dysfunction in the Liver and Antiphospholipid Antibody Production Precede Disease Onset and Respond to Rapamycin in Lupus-Prone Mice","volume":"68","author":"Oaks","year":"2016","journal-title":"Arthritis Rheuma"},{"issue":"3","key":"10.1016\/j.biopha.2024.116261_bib88","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/ni.1980","article-title":"Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome","volume":"12","author":"Nakahira","year":"2011","journal-title":"Nat. Immunol."},{"issue":"11","key":"10.1016\/j.biopha.2024.116261_bib89","doi-asserted-by":"crossref","first-page":"9587","DOI":"10.1074\/jbc.M110.202911","article-title":"Autophagy controls IL-1beta secretion by targeting pro-IL-1beta for degradation","volume":"286","author":"Harris","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.biopha.2024.116261_bib90","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/ni.2215","article-title":"Activation of autophagy by inflammatory signals limits IL-1\u03b2 production by targeting ubiquitinated inflammasomes for destruction","volume":"13","author":"Shi","year":"2012","journal-title":"Nat. Immunol."},{"issue":"7329","key":"10.1016\/j.biopha.2024.116261_bib91","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature09663","article-title":"A role for mitochondria in NLRP3 inflammasome activation","volume":"469","author":"Zhou","year":"2011","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.biopha.2024.116261_bib92","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1093\/gerona\/glz239","article-title":"NLRP3 Inflammasome Inhibition by MCC950 in Aged Mice Improves Health via Enhanced Autophagy and PPAR\u03b1 Activity","volume":"75","author":"Mar\u00edn-Aguilar","year":"2020","journal-title":"J. Gerontol. A Biol. Sci. Med Sci."},{"issue":"59","key":"10.1016\/j.biopha.2024.116261_bib93","doi-asserted-by":"crossref","first-page":"99740","DOI":"10.18632\/oncotarget.20763","article-title":"NLRP3-inflammasome inhibition prevents high fat and high sugar diets-induced heart damage through autophagy induction","volume":"8","author":"Pavillard","year":"2017","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.biopha.2024.116261_bib94","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24076309","article-title":"Hyperglycemia Aggravates Periodontitis via Autophagy Impairment and ROS-Inflammasome-Mediated Macrophage Pyroptosis","volume":"24","author":"Zhao","year":"2023","journal-title":"Int J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.biopha.2024.116261_bib95","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1136\/ard.2010.140111","article-title":"Genetic association of PRDM1-ATG5 intergenic region and autophagy with systemic lupus erythematosus in a Chinese population","volume":"70","author":"Zhou","year":"2011","journal-title":"Ann. Rheum. Dis."},{"issue":"8","key":"10.1016\/j.biopha.2024.116261_bib96","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/1346-8138.15929","article-title":"Role of necroptosis in infection-related, immune-mediated, and autoimmune skin diseases","volume":"48","author":"Liu","year":"2021","journal-title":"J. Dermatol."},{"issue":"10","key":"10.1016\/j.biopha.2024.116261_bib97","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/nrm2970","article-title":"Molecular mechanisms of necroptosis: an ordered cellular explosion","volume":"11","author":"Vandenabeele","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.biopha.2024.116261_bib98","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ebiom.2019.06.016","article-title":"Clearance of apoptotic cells by mesenchymal stem cells contributes to immunosuppression via PGE2","volume":"45","author":"Zhang","year":"2019","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.biopha.2024.116261_bib99","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.clim.2007.10.003","article-title":"SLE serum induces classical caspase-dependent apoptosis independent of death receptors","volume":"126","author":"Bengtsson","year":"2008","journal-title":"Clin. Immunol."},{"issue":"5","key":"10.1016\/j.biopha.2024.116261_bib100","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1136\/ard.58.5.309","article-title":"Increased apoptotic peripheral blood neutrophils in systemic lupus erythematosus: relations with disease activity, antibodies to double stranded DNA, and neutropenia","volume":"58","author":"Courtney","year":"1999","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.biopha.2024.116261_bib101","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/1756-185X.12568","article-title":"Incomplete clearance of apoptotic cells in systemic lupus erythematosus: pathogenic role and potential biomarker","volume":"18","author":"Jung","year":"2015","journal-title":"Int J. Rheum. Dis."},{"issue":"10","key":"10.1016\/j.biopha.2024.116261_bib102","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1002\/art.11237","article-title":"Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosus","volume":"48","author":"Ren","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.biopha.2024.116261_bib103","doi-asserted-by":"crossref","first-page":"3638562","DOI":"10.1155\/2019\/3638562","article-title":"Programmed Cell Death Pathways in the Pathogenesis of Systemic Lupus Erythematosus","volume":"2019","author":"Yang","year":"2019","journal-title":"J. Immunol. Res"},{"key":"10.1016\/j.biopha.2024.116261_bib104","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.3389\/fimmu.2018.01957","article-title":"Up-Regulation of TLR7-Mediated IFN-\u03b1 Production by Plasmacytoid Dendritic Cells in Patients With Systemic Lupus Erythematosus","volume":"9","author":"Sakata","year":"2018","journal-title":"Front Immunol."},{"issue":"5938","key":"10.1016\/j.biopha.2024.116261_bib105","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1126\/science.1172308","article-title":"RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis","volume":"325","author":"Zhang","year":"2009","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.biopha.2024.116261_bib106","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1613305114","article-title":"Active MLKL triggers the NLRP3 inflammasome in a cell-intrinsic manner","volume":"114","author":"Conos","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2024.116261_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102890","article-title":"Pathological mechanisms and crosstalk among different forms of cell death in systemic lupus erythematosus","volume":"132","author":"Xu","year":"2022","journal-title":"J. Autoimmun."},{"issue":"9","key":"10.1016\/j.biopha.2024.116261_bib108","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.375","article-title":"Activation-induced necroptosis contributes to B-cell lymphopenia in active systemic lupus erythematosus","volume":"5","author":"Fan","year":"2014","journal-title":"Cell Death Dis."},{"issue":"43","key":"10.1016\/j.biopha.2024.116261_bib109","doi-asserted-by":"crossref","first-page":"69371","DOI":"10.18632\/oncotarget.12674","article-title":"Blocking TCR restimulation induced necroptosis in adoptively transferred T cells improves tumor control","volume":"7","author":"Kesarwani","year":"2016","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.biopha.2024.116261_bib110","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/s41401-021-00749-7","article-title":"Gout-associated monosodium urate crystal-induced necrosis is independent of NLRP3 activity but can be suppressed by combined inhibitors for multiple signaling pathways","volume":"43","author":"Zhong","year":"2022","journal-title":"Acta Pharm. Sin."},{"issue":"4","key":"10.1016\/j.biopha.2024.116261_bib111","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/FJC.0000000000000053","article-title":"A novel pharmacologic inhibitor of the NLRP3 inflammasome limits myocardial injury after ischemia-reperfusion in the mouse","volume":"63","author":"Marchetti","year":"2014","journal-title":"J. Cardiovasc Pharm."},{"issue":"2","key":"10.1016\/j.biopha.2024.116261_bib112","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1074\/jbc.M113.515080","article-title":"3,4-methylenedioxy-\u03b2-nitrostyrene inhibits NLRP3 inflammasome activation by blocking assembly of the inflammasome","volume":"289","author":"He","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.biopha.2024.116261_bib113","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1084\/jem.20171419","article-title":"Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders","volume":"214","author":"Jiang","year":"2017","journal-title":"J. Exp. Med"},{"issue":"7","key":"10.1016\/j.biopha.2024.116261_bib114","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1716095115","article-title":"OLT1177, a \u03b2-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation","volume":"115","author":"Marchetti","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.biopha.2024.116261_bib115","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201708689","article-title":"Tranilast directly targets NLRP3 to treat inflammasome-driven diseases","volume":"10","author":"Huang","year":"2018","journal-title":"EMBO Mol. Med"},{"issue":"1","key":"10.1016\/j.biopha.2024.116261_bib116","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1038\/s41467-018-04947-6","article-title":"Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity","volume":"9","author":"He","year":"2018","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biopha.2024.116261_bib117","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1083\/jcb.200903124","article-title":"Glyburide inhibits the Cryopyrin\/Nalp3 inflammasome","volume":"187","author":"Lamkanfi","year":"2009","journal-title":"J. Cell Biol."},{"issue":"4","key":"10.1016\/j.biopha.2024.116261_bib118","doi-asserted-by":"crossref","first-page":"5160","DOI":"10.1002\/jcb.27792","article-title":"Rapamycin combined with MCC950 to treat multiple sclerosis in experimental autoimmune encephalomyelitis","volume":"120","author":"Xu","year":"2019","journal-title":"J. Cell Biochem"},{"issue":"3","key":"10.1016\/j.biopha.2024.116261_bib119","doi-asserted-by":"crossref","first-page":"522","DOI":"10.55563\/clinexprheumatol\/eakvlv","article-title":"Activation of caspase-1 is mediated by stimulation of interferon genes and NLR family pyrin domain containing 3 in monocytes of active systemic lupus erythematosus","volume":"40","author":"Inokuchi","year":"2022","journal-title":"Clin. Exp. Rheuma"},{"issue":"8","key":"10.1016\/j.biopha.2024.116261_bib120","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202100047R","article-title":"Cf-02, a novel benzamide-linked small molecule, blunts NF-\u03baB activation and NLRP3 inflammasome assembly and improves acute onset of accelerated and severe lupus nephritis in mice","volume":"35","author":"Yang","year":"2021","journal-title":"Faseb J."},{"issue":"12","key":"10.1016\/j.biopha.2024.116261_bib121","first-page":"1846","article-title":"[Effects of serum from Xinfeng capsule-treated rats on lipopolysaccharide-induced pyroptosis in rheumatoid arthritis synovial fibroblasts]","volume":"42","author":"Wang","year":"2022","journal-title":"Nan Fang. Yi Ke Da Xue Xue Bao"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224001422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224001422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:49:01Z","timestamp":1760104141000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224001422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":121,"alternative-id":["S0753332224001422"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116261","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic potential of MCC950, a specific inhibitor of NLRP3 inflammasome in systemic lupus erythematosus","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116261","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116261"}}